1.
Bioorg Med Chem Lett
; 18(13): 3695-700, 2008 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18522867
RESUMO
The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety are reported. They showed binding affinities up to 1nM towards the CB2 receptor with partial to full agonist potencies. They also demonstrated good to excellent selectivity (>1000-fold) over the CB1 receptor.